Combined Spinal-Epidural Temperature and Duration of Action

Completed · Phase 2

Conditions studied: Pain

In brief

The hypothesis is that a combined spinal-epidural drug at refrigerated temperature will have a shorter period of pain relief than that maintained at room temperature. The temperature of the dose of medication will be measure with an infrared thermometer immediately prior (within 5 minutes) to administration.

Key facts

Study ID
NCT02020304
Run by
Wake Forest University Health Sciences
People needed
58
Starts
2013-08-29
Expected to finish
2014-05-04
Last updated by the study team
2018-09-10

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.